Donald F Brophy

9PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)Tissue engineeringBio-fluidsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 29, 2021
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiency.

Erika J Martin, Melinda E Nolte, Janice Kuhn

|Dec 11, 2019
Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health.

Naren Gajenthra Kumar, Daniel Contaifer, Parthasarathy Madurantakam

|Jul 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas.

Sunita Patel-Hett, Erika J Martin, Bassem M Mohammed

|Nov 16, 2018
Thromboelastographic analysis of novel polyethylene glycol based low volume resuscitation solutions.

Loren K Liebrecht, Jason Newton, Erika J Martin

|Oct 20, 2018
A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.

Rio S Boothello, Nirmita J Patel, Chetna Sharon

|Aug 17, 2018
Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activation.

Donald F Brophy, Erika J Martin, Marisa Ninivaggi

Pageof 2